Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
BIO-key International | BKYI | Jan 17, 2025 | 1.73 | -18.01 |
Bio-Path | BPTH | Jan 17, 2025 | 0.82 | +0.74 |
Bio-Rad Laboratories A | BIO | Jan 17, 2025 | 342.41 | -0.60 |
Bio-Rad Laboratories B | BIO-B | Jan 17, 2025 | 341.00 | 0.00 |
Bio-Techne | TECH | Jan 17, 2025 | 75.83 | -0.35 |
BioAffinity Technologies | BIAF | Jan 17, 2025 | 0.68 | -6.76 |
BioAge Labs | BIOA | Jan 17, 2025 | 5.14 | +1.98 |
BioAtla | BCAB | Jan 17, 2025 | 0.49 | +1.46 |
BioCardia | BCDA | Jan 17, 2025 | 2.18 | +2.78 |
Bioceres Crop Solutions | BIOX | Jan 17, 2025 | 6.89 | -0.29 |
BioCryst Pharmaceuticals | BCRX | Jan 17, 2025 | 7.45 | +5.52 |
Biodesix | BDSX | Jan 17, 2025 | 1.15 | +0.88 |
Biodexa Pharma ADR | BDRX | Jan 17, 2025 | 4.28 | -1.38 |
Biofrontera | BFRI | Jan 17, 2025 | 1.10 | +2.80 |
Biogen | BIIB | Jan 17, 2025 | 140.55 | -0.48 |
BioHarvest Sciences | BHST | Jan 17, 2025 | 5.83 | 0.00 |
Biohaven | BHVN | Jan 17, 2025 | 37.59 | +4.85 |
BioLife Solutions | BLFS | Jan 17, 2025 | 26.14 | -1.17 |
BioLineRX ADR | BLRX | Jan 17, 2025 | 0.10 | -16.74 |
BioMarin Pharmaceutical | BMRN | Jan 17, 2025 | 61.53 | +0.46 |
Biomea Fusion | BMEA | Jan 17, 2025 | 3.98 | -2.09 |
Biomerica | BMRA | Jan 17, 2025 | 0.64 | -9.35 |
BiomX | PHGE | Jan 17, 2025 | 0.77 | +0.95 |
Bionano Genomics | BNGO | Jan 17, 2025 | 0.19 | -5.89 |
BioNexus Gene Lab | BGLC | Jan 17, 2025 | 0.38 | -0.66 |
BioNTech ADR | BNTX | Jan 17, 2025 | 111.93 | -0.74 |
BioRestorative Therapies | BRTX | Jan 17, 2025 | 1.97 | -2.72 |
BioShares Biotechnology Clinical Trials Fund | BBC | Jan 17, 2025 | 21.83 | +0.04 |
BioShares Biotechnology Products Fund | BBP | Jan 17, 2025 | 60.15 | +0.25 |
biote | BTMD | Jan 17, 2025 | 5.64 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.